In the the Tafas v. Kappos lawsuit, Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office David Kappos and the U.S. Patent and Trademark Office filed a joint motion for dismissal of the appeal and to vacate the judgment of the district court below because the USPTO […]
The next quarterly meeting of the U.S. Patent and Trademark Office’s Biotechnology and Chemical Pharmaceutical Customer Partnership is scheduled: Wednesday, December 9, 2009 from 10:00 am to 5:00 pm Auditorium in Madison East, 600 Dulany Street, Alexandria, Virginia. The Biotechnology and Chemical Pharmaceutical Customer Partnership is designed and developed to be a forum to share […]
Association for Molecular Pathology, et al. v. U.S. Patent and Trademark Office, et al., a suit by the American Civil Liberties Union and joined by the Public Patent Foundation, challenges the patentability of gene patents on two human genes associated with breast and ovarian cancer. Along with claims that the patents are illegal, the group […]
A Telecast by the Program on Information Justice and Intellectual Property, Washington College of Law, American University and the Federal Circuit Bar Association are presenting a telecast on Patentable Subject Matter After the Bilski Oral Argument. Date: November 19, 2009 Place: Washington College of Law Time: 4:30- 6:30 p.m. EST In Bilski v. Kappos, the […]
The Supreme Court finally heard oral arguments in the Bilski v. Doll case and everyone has something to say about it. Whether the Court will make a narrow ruling on that the claim at issue is not patent eligible subject matter rather than some broad ruling that would cover all methods patents is certainly likely […]
The Supreme Court finally heard oral hearings in the Bilski v. Doll case. Here, the Court was asked to consider whether the Federal Circuit erred by holding that a “process” must be tied to a particular machine or apparatus, or transform a particular article into a different state or thing (“machine-or-transformation” test), to be eligible […]
It is good that authors should be remunerated; and the least exceptionable way of remunerating them is by a monopoly. Yet monopoly is an evil. For the sake of the good we must submit to the evil; but the evil ought not to last a day longer than is necessary for the purpose of securing […]
A federal district court said that the ACLU et al. suit challenging the patentability of gene patents can go forward. The American Civil Liberties Union (ACLU), the Public Patent Foundation (PUBPAT), and a whole host of others have filed a lawsuit challenging patents on two human genes associated with breast and ovarian cancer claiming that […]
Served Up Daily
Editor-in-Chief Barista Stephen Jenei is a patent attorney and Owner of Jenei LLC. When not serving up patent chat over a steaming cup of java, he's handling a diverse intellectual property practice in the biotechnology, pharmaceutical and chemical fields. More info @ Jenei LLC
